EGFR and cancer: The KEGG enrichment analysis showed that the hub genes had significant enrichment in EGFR tyrosine kinase inhibitor resistance, Hepatitis B, Acute myeloid leukemia, and Proteoglycans in cancer pathway (Fig. 2D).